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Abstract 
We previously reported the bioavailability enhancement of lipophilic Coenzyme Q10 (CoQ10) by complexing with Ȗ-
Cyclodextrin (ȖCD). Here, we report on its mechanism. Hydrophobic CoQ10 generally agglutinates but the 
dissociated CoQ10 from ȖCD was captured by bile acid to form nanometer molecular micelle without aggregation 
and therefore both solubility and bioavailability could be enhanced. Furthermore, we succeeded in the expansion of 
this finding to personal care field by the use of Dipotassium glycyrrhizate (GZK2) instead of bile acid. The skin 
absorptions of actives could be significantly enhanced by the combination of cosme-ceutical-ȖCD complexes with 
GZK2. 
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1. Introduction 
Cyclodextrins (CDs) are cyclic oligosaccharides consisting of six, seven and eight glucopyranose 
residues (Į, ȕ and ȖCDs respectively) bound by Į-1,4 glycosidic linkages. CDs have a bucket shape form 
with a hydrophobic cavity and hydrophilic surface. This unique bucket shape allows inclusion complexes 
with various hydrophobic substances to improve unfavorable characteristics such as low stability, low 
water solubility and low bioavailability. Due to the benefits, CDs are frequently used in pharmaceutical 
formulations. Here not natural CDs but chemically modified CDs are often utilized because of higher 
water solubilizing power than parent CDs [1-4]. 
In the contrast, chemically modified CDs cannot be utilized for nutra-ceutical applications from a 
viewpoint of safety and bioadaptability, because nutra-ceuticals are daily taken for a long period in large 
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amount, and some chemically modified CDs have a membrane-perturbing effect, resulting in hemolysis 
and local irritation at higher doses. Therefore, natural CDs are only alternative CDs to be used for 
improvement of aqueous solubility and bioavailability of nutra-ceuticals. 
In this context, we studied the effect of natural Į, ȕ and ȖCDs on the aqueous solubility and 
bioavailability of some hydrophobic nutra-ceuticals such as Coenzyme Q10 (CoQ10) [5-7], Curcumin [8, 
9], Tocotrienol [10], R-Į-Lipoic acid [11], Menaquinone-7 (Vitamin K2) and Astaxanthin. Complex 
formations with all natural CDs do not help to enhance aqueous solubility of such nutra-ceuticals in 
general. But interestingly bioavailability of many kinds of lipophilic bioactives could be significantly 
enhanced when ȖCD is especially used. 
There are three types of approaches for bioavailability enhancement of bioactives, focusing on 
maximum plasma concentration of actives (Cmax) and half life time (T1/2) of maximum plasma 
concentration time (Tmax) of actives in blood plasma (Fig. 1). One is the Cmax enhancer. Commercially 
available “Water soluble CoQ10” formulation using fatty oil based emulsifier is known as one of the 
typical examples for enhancing Cmax but without giving prolongation of T1/2 in comparison with the dotted 
line for the general CoQ10 formulation (Type 1) [12]. The other type of the aides works to prolong T1/2. 
For example, the glucosidated bioactives like ascorbic acid 2-glucoside give T1/2 prolongation of ascorbic 
acid due to slow cleavage of glucose bond by glycosdase in intestine [13]. But due to the slow release of 
the bioacitive into blood, Cmax becomes somewhat lower (Type 2). In comparison with those approaches, 
the inclusion complex formation of hydrophobic substances with ȖCD can work for both enhancing Cmax 
and prolonging T1/2 and therefore gives the highest area under the blood concentration-time curve (AUC) 
(Type 3). 
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Fig. 1. 3 types of bioavailability enhancement by Cyclodextrin. ʊAbsorption and sustention in bloodʊ 
For example, we have previously reported the bioavailability enhancement of hydrophobic CoQ10 by 
the complexation with ȖCD which showed unique profile along the line with Type 3. CoQ10 
concentration changes in blood plasma were evaluated after oral administrations by three different 
formulations, CoQ10-ȖCD complex, CoQ10 with fatty oil based emulsifier so called “water soluble 
CoQ10” and CoQ10-micro crystalline cellulose (MCC) mixture on fasted human subjects. The 
administration of CoQ10-ȖCD complex showed the highest Cmax and the longest T1/2 of CoQ10 in blood 
plasma among three formulations as shown in Fig. 2. 
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Fig. 2. Time course of plasma level of CoQ10 after an oral administration of CoQ10 with 3 different formulations, CoQ10-ȖCD 
complex, CoQ10 with oil emulsifier and CoQ10-MCC mixture for 72 healthy adult subjects (CoQ10 intake: 30 mg per subject). 
In the beginning of our study on bioavailability of CoQ10-ȖCD complex, we did not have any clear 
explanations for the mechanism why significantly enhanced bioavailability of CoQ10 could be observed 
in spite of poorly aqueous soluble characteristics of CoQ10-ȖCD complex. However, we have recently 
found the most plausible explanation which includes the significant increase of the aqueous solubility of 
CoQ10 with the aid of sodium taurocholate (Na TCA) as a constituent of bile acid in small intestine. 
CoQ10-ȖCD complex has extremely poor water solubility. But the water solubility of CoQ10 could be 
significantly improved by the addition of Na TCA to CoQ10-ȖCD complex. Its plausible mechanism is as 
follows. A water soluble Na TCA-ȖCD complex was formed by substituting the guest molecule from 
CoQ10 to Na TCA which has higher association constant with ȖCD than CoQ10. The association 
constants of ȖCD complex with Na TCA and CoQ10 are respectively 3100 M-1 and 2200 M-1 [14]. CoQ10 
molecule dissociated from ȖCD complex could be solubilised in water captured one by one in the midst of 
Na TCA micelle, in other words, “molecular captured micelle” whereas hydrophobic CoQ10 molecule 
agglutinates in water to form visible particles in general. 
The aqueous solubility of CoQ10 by this method was ca. 100 times higher than that of commercially 
available oil emulsifier formulation “water soluble CoQ10” whose particle size was controlled around 
100 nm in diameter. By the formation of “molecular captured micelle”, it is thought that the significant 
high AUC could be observed via effective absorption into intestinal epithelial cells on the molecular level. 
This method could be applied for not only CoQ10 but also the other nutra-ceuticals like Curcumin, 
Tocotrienol, Vitamin K2 and R-Į-Lipoic acid having human health benefits. 
In the wake of the breakthrough project using CoQ10-ȖCD complex and Na TCA, we could also 
establish this new molecular captured micelle formulation system in cosme-ceutical field by the 
combination of ȖCD complex with dipotassium glycyrrhizate (GZK2) which has high association constant 
and possesses hydrophilic region to form water soluble GZK2 complex as well as Na TCA (Fig. 3) [15, 
16]. Here we observed much higher CoQ10 intake into a human epidermis structure model by the 
formulation of CoQ10-ȖCD complex with GZK2 compared to the other cosmetic formulations for 
example using liposome and fatty oil based emulsifiers. 
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Fig. 3. The structures of Na TCA and GZK2 ȖCD complexes. 
2. Study on solubility enhancing effects of hydrophobic bioactives by adding Na TCA or GZK2 to 
ȖCD complex 
2.1. Materials 
CoQ10 was obtained from Mitsubishi Gas Chemical Company, Inc. CoQ10-ȖCD complex containing 
20 % (wt/wt) CoQ10 was supplied from Wacker Chemical Corporation (Adrian, Michigan) as product 
named CAVAMAX® W8 CoQ10. CoQ10-ĮCD complex and CoQ10-ȕCD complex were prepared by a 
conventional spray-dry method. GZK2 was donated by Tokiwa Phytochemical Co., Ltd. Na TCA was 
purchased from Wako Pure Chemical Industries, Ltd. 1-Adamantane carboxylic acid (AdCA) was 
purchased from Tokyo Chemical Industries, Ltd. 
Curcumin-ȖCD complex containing 14 % (wt/wt) of curcuminoids was supplied from Wacker 
Chemical Corporation (Adrian, Michigan) as product named CAVAMAX® W8 Curcumin. 
2.2. Water solubility changes of CoQ10 by various CoQ10 formulations 
Adding effect of Na TCA to CoQ10-ȖCD complex on water solubility enhancement of CoQ10: CoQ10 
concentrations for four types of formulated CoQ10 samples prepared as described below were measured 
by HPLC. Shimadzu HPLC system (LC-2010C) was used for the measurement of CoQ10 concentration in 
the aqueous solution. Phenomenex HPLC column (Luna 5u C18(2) 100A : 4.6 mm I.D. x 150 mm) was 
used. Column temperature was set at 35°C. A mixture of methanol, ethanol and distilled water (60 : 40 : 
1) was used as mobile phase with the flow rate of 0.8 mL/min. CoQ10 was detected using UV detector at 
275 nm. 
1) CoQ10-ȖCD complex with Na TCA: A mixture of 33 mg of Na TCA with 60 mg of CoQ10-ȖCD 
complex containing 12 mg of CoQ10 was added into 3 mL of Milli-Q water. 2) CoQ10-ȖCD complex: 60 
mg of CoQ10-ȖCD complex containing 12 mg of CoQ10 was added into 3 mL of Milli-Q water. 3) Water 
soluble CoQ10: To a solution of 33 mg of N-cocoyl-L-arginine ethyl ester-DL-pyrrolidone carboxylate 
salt (CAE) as amino acid cationic surfactant in 3 mL of Milli-Q water, 12 mg of CoQ10 was added. 4) 
Pure CoQ10: 12 mg of CoQ10 was added to 3 mL of Milli-Q water. The resultant suspensions were 
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sonicated for 30 min and filtrated through 0.2 μm PTFE filter to get transparent solution containing 
CoQ10. 
Results and Discussions: CoQ10 is poorly soluble in water due to its lipophilic side chain constructed 
with 10 mono-unsaturated trans-isoprenoid units. Even after sonication, the water solubility was only 0.3 
μg/mL. The complex formation with ȖCD did not help so much to enhance the water solubility of CoQ10. 
Its CoQ10 concentration was 2.9 μg/mL. On the other hand, the addition of Na TCA to CoQ10-ȖCD 
complex assisted a great deal of the solubility enhancement of CoQ10. In fact, adding Na TCA to the 
cloudy water suspension of CoQ10-ȖCD complex, it was observed to be transparent clear solution. The 
CoQ10 concentration of the solution obtained from the formulation of CoQ10-ȖCD complex with Na 
TCA was surprisingly high at 1147.5 μg/mL, which is more than 100 times higher than that of “water 
soluble CoQ10” formulation using amino acid cationic surfactant, CAE (11.4 μg/mL) as shown in Fig. 4. 
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Fig. 4. Water solubility changes of CoQ10 by 3 different formulations in comparison with CoQ10-ȖCDcomplex with Na TCA, 
CoQ10-ȖCD complex, water soluble CoQ10 formulation using amino acid cationic surfactant, CAE, pure CoQ10. 
The role of Na TCA for this significant solubilizing effect is thought to be due to the formation of 
water soluble Na TCA-ȖCD complex by substituting the guest molecule from CoQ10 to Na TCA which 
has higher association constant with ȖCD than CoQ10, followed by the formation of molecular captured 
micelle of dissociated CoQ10 with Na TCA. The structure of Na TCA can be divided into hydrophilic 
region and hydrophobic region. The hydrophobic region is entrapped by excellent fit in ȖCD cavity. The 
hydrophilic region is placed outside of the cavity and is accordingly thought to be the reason for the high 
water solubility of Na TCA-ȖCD complex. GZK2 is also known to form water soluble complex with ȖCD 
due to the similar structure to Na TCA as described in Fig. 3. Therefore, in order to pursue whether our 
conjecture is right or not, our second study was the evaluation of the water solubility changes of CoQ10 
by the addition of GZK2 to CoQ10-ȖCD complex compared with just a mixture of pure CoQ10 with 
GZK2. The water solubility of CoQ10 was not enhanced at all by adding GZK2 to the suspension of pure 
CoQ10 in water. But by adding GZK2 to CoQ10-ȖCD complex suspension, the water solubility of CoQ10 
increased with increasing added GZK2 amount. Significantly high CoQ10 water solubility (more than 
2000 μg/mL) was achievable by higher GZK2/CoQ10 molecular ratio than 10. The results might show 
that only one molecule of GZK2 is required for the formation of GZK2-ȖCD complex but around 10 
molecules of GZK2 are essential for solubizing one molecule of dissociated CoQ10 by the formation of 
molecular micelle of GZK2 entrapping CoQ10. 
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2.3. Water solubility enhancement of CoQ10 by adding GZK2 and AdCA to three CoQ10-natural CD 
complexes 
Adding effect of GZK2 on water solubility enhancement of CoQ10 to three natural CD complexes: 
CoQ10-CD complex (10 mg) was weighed in a vial. GZK2 (molar ratios against CoQ10 are 0, 3, 5, 7, 10, 
20, 30 and 40) were added in the vials, followed by addition of Milli-Q water (5 mL). The resultant 
suspensions were sonicated for 30 min, and filtrated through 0.2 μm PTFE filter to get transparent 
solution containing CoQ10. The concentrations of CoQ10 for all samples were measured by HPLC. The 
same Shimadzu HPLC system (LC-2010C) was used as above experiment. 
Influence by adding AdCA to the water solubility enhancing system by the combination of CoQ10-CD 
complexes with GZK2: CoQ10-CD complex (10 mg) was weighed in a vial. GZK2 (molar ratios against 
CoQ10 are 0, 3, 5, 7, 10, 20, 30 and 40) and AdCA (10 mg) were added in the vials, followed by addition 
of Milli-Q water (5 mL). The resultant suspensions were sonicated for 30 minutes, and filtered through 
0.2 μm PTFE filter to get transparent solution containing CoQ10. Then, the concentrations of CoQ10 for 
all samples were measured by HPLC. 
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Fig. 5. Water solubility changes of CoQ10 by the combination of three CoQ10-natural CD complexes with GZK2 (left line graph) 
and with GZK2 and AdCA (right line graph). 
Results and Discussions: The water solubility changes of CoQ10 by the combination of CoQ10-three 
natural CD complexes with GZK2 were shown in the left line graph of Fig. 5. Increasing molecular ratio 
of GZK2 to CoQ10 gives outstanding higher CoQ10 concentration in case of the combination of CoQ10-
ȖCD complex (CoQ10Ȗ) with GZK2, whereas no significant increase could be observed using CoQ10-
ĮCD complex (CoQ10Į) and CoQ10-ȕCD complex (CoQ10ȕ). This excellent solubility enhancing effect 
of GZK2 is thought to be due to high association constant of GZK2 with ȖCD to form GZK2-ȖCD complex 
by substituting the guest molecule from CoQ10 followed by the formation of CoQ10 molecular captured 
micelle with GZK2. The association constants of GZK2 with ĮCD and ȕCD are relatively too low to 
substitute CoQ10 for the formation of GZK2-CD complexes. 
AdCA is known to have extremely high association constant with ȕCD as well as the association 
constant between GZK2 and ȖCD [17]. Then, our next evaluation was the adding effect of AdCA on the 
water solubility changes of CoQ10 by the combination of three natural CD complexes with GZK2. As 
shown in right line graph of Fig. 5, the significant increase of CoQ10 concentration was observed by the 
addition of AdCA to CoQ10-ȕCD complex (CoQ10ȕ) with GZK2 with almost same CoQ10 concentration 
increasing ratio by the combination of ȖCD complex with GZK2. We believe that this observation 
supports our plausible explanation mechanism for the formation of GZK2-ȖCD complex or AdCA-ȕCD 
complex, followed by CoQ10 molecular captured micelle formation with GZK2. 
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2.4. Water solubility enhancement of Curcumin by adding Na TCA to its ȖCD complex 
Sample Preparation: 1) Addition of Na TCA to physical mixture of Curcumin with ȖCD: 6.6 mg of 
Curcumin and 43 mg of ȖCD were added into 2 mL of deionized water with the calculated amount of Na 
TCA (molar ratio of ȖCD to Na TCA is 1 : 2) in a micro tube. 2) Addition of Na TCA to Curcumin-ȖCD 
complex: 50 mg of Curcumin-ȖCD complex containing 6.6 mg of Curcumin was weighed and added into 
2 mL of deionized water containing calculated amount of Na TCA (molar ratio of ȖCD in the complex to 
Na TCA is 1 : 2) in a micro tube. 3) Addition of Na TCA to Curcumin: 6.6 mg of the Curcumin was 
added into 2 mL of deionized water containing Na TCA in a micro tube. Three of resultant suspensions 
were then physically mixed well and used for the measurements. 4) Curcumin-ȖCD complex without 
adding Na TCA as a comparison sample, was just dispersed in deionized water and used for the 
measurement. 
Measurement of Curcumin content: Shimadzu HPLC system (LC-2010C) was used for the 
measurement of Curcumin fixing Sunfire HPLC column (ODS: 4.6 mm I.D. x 100 mm). The column 
temperature was set at 40°C. Mobile phase of 10 mM NaH2PO4 (pH 2.6) : MeOH = 3 : 7 was used at the 
flow rate of 0.8 mL/min. Curcumin was detected using UV detector at 430 nm. 
Results and Discussions: The aim of this study is to evaluate the generality of our findings with regard 
to the water solubility and bioavailability enhancements of lipophilic bioactives by molecular captured 
micelle formation technology using ȖCD. Curcumin in turmeric has attracted a lot of attention of 
researchers in the fields of Alzheimer’s disease, memory deficits, arthritis, cancer, including breast cancer 
and diabetes because of its strong antioxidant and anti-inflammatory characteristics. But Curcumin is a 
lipophilic substance and hard soluble in water so that it is known to have extremely low bioavailability as 
same as CoQ10. H. Reuscher studied the bioavailability enhancement of Curcumin by the administration 
of Curcumin-ȖCD complex in vivo on rats [18]. According to his study, the concentration of Curcumin in 
blood plasma was raised up very much after single administration of Curcumin-ȖCD complex showing 
extremely high AUC and Cmax whereas only slight increase of Curcumin concentration in blood plasma 
was shown after the administration of commercially available Curcumin formulation using oil emulsifier 
advocating high bioavailability as shown in Fig. 6. 
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Fig. 6. Bioavailability enhancement of Curcumin by single administration of Curcumin-ȖCD complex to rats (Curcumin content: 
500 mg/kg weight). 
In the same manner as the evaluation for CoQ10, -ȖCD complex, we evaluated the water solubility 
enhancement by the combination of Curcumin-ȖCD complex with Na TCA. The complex formation of 
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Curcumin with ȖCD or just the addition of Na TCA to Curcumin did not help to enhance the solubility of 
Curcumin in water at all. But as we anticipated, by adding Na TCA to not physical mixture of Curucumin 
with ȖCD but Curcumin-ȖCD complex, the water solubility of Curcumin was significantly enhanced (Fig. 
7). We believe that our results show the reason of bioavailability enhancement of Curcumin which is due 
to the aid of bile acids in small intestine of rats. The absorption of Curcumin was enhanced by the 
formation of Curcumin molecular captured micelle with bile acids after releasing from its ȖCD complex. 
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Fig. 7. Water solubility changes of Curcumin by 4 different formulations, Curcumin-ȖCD complex, Curcumin with Na TCA, 
physical mixture of Curcumin+ȖCD with Na TCA, Curcumin-ȖCD complex with Na TCA. 
3. In vitro study on epidermis absorption enhancing effect of CoQ10 by adding GZK2 to its ȖCD 
complex 
3.1. Materials 
The human three-dimensional cultured epidermal model “LabCyte EPI-MODEL” was purchased from 
Japan Tissue Engineering Co., Ltd. This is multi-layered epidermal model cultured by using normal 
human skin cells. It consisted of multiple and viable cell layers and contained basal layer, stratum 
spinosum epidermidis, granular layer and stratum corneum. It’s characterized by the morphological 
resemblance to human skin. Since human cells are utilized, the test result could be extrapolated to the 
actual human skin response. Test results are reproducible because of small well-to-well and lot-to-lot 
variation (Fig. 8) [19]. Since cells maintain metabolic activity, it can also be applied to the 
pharmacological test of various drugs, cosmetics and so on. Liposome CoQ10 was obtained from Croda 
Japan KK. 
3.2. Methods, Results and Discussions 
The tissue cultures were preincubated for 18 h at 37°C in 5 % CO2 environment. Then the tissues were 
placed into well plate with 1 mL assay medium dispensed. After each 0.2 mL test materials were added to 
the tissues, they were incubated for more than 6 h at 37°C in 5 % CO2 environment. The tissues were 
rinsed five times with 1 mL of 0.1 M phosphate buffered saline (PBS). The content of absorbed CoQ10 in 
the tissues was extracted with 5 mL of chloroform : methanol (1 : 1) by shaking for 30 min. Then 
extracted solvent was evaporated by using centrifugal concentrator. After drying, to the evaporated 
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residue was added 0.7 mL ethanol including 0.1 mL of iron chloride in ethanol solution (1 mg/mL) as 
oxidizing reagent. It was filtered through 0.2 μm PTFE filter, and its CoQ10 content in the tissue culture 
was analyzed by Shimadzu LCMS system (LCMS-2020). Phenomenex HPLC column (Luna 5u C18(2) 
100A : 4.6 mm I.D. x 150 mm) was used. Column temperature was set at 35°C. The mobile phase was 
used with a mixture of acetonitrile and isopropanol (8 : 7) containing 0.5 % formic acid and 0.1 % 
trisodium citrate aqueous solution (1 mg/mL), with the flow rate of 0.2 mL/min. The mass spectrometer 
fitted with an electro spray ionisation (ESI) source was used for analysis. It was operated in the positive 
ion mode with the following parameters: probe voltage +4.50 kV (+ESI), nebulizer gas flow 1.5 L/min, 
drying gas flow 15.0 L/min, block heater 200°C, DL temperature 250°C. 
 
 
Fig. 8. Histological cross-sectional views of LabCyte EPI-MODEL with H&E staining. 
 
Preparation of samples: 60 mg CoQ10-ȖCD complex containing 12 mg of CoQ10 and 33 mg of GZK2 
were added into 3 mL of Milli-Q water. The resultant suspension was sonicated for 30 min, and filtered 
through 0.2 μm PTFE filter. The concentration of CoQ10 in the aqueous solution was ca. 1000 μg/mL. 
The suspensions of pure CoQ10, CoQ10-ȖCD complex and physical mixture of CoQ10 with GZK2 were 
prepared without filtering as comparative samples containing 1000 μg/mL of CoQ10. 
Results and Discussions: CoQ10 absorption study using an in vitro digestion-Caco-2 cell model has 
already been reported by H. N. Bhagavan et al. In their study, various commercially available CoQ10 
formulation products were subjected to simulated digestion to mimic their passage through the 
gastrointestinal tract to generate micelles containing CoQ10 and bile acids like taurocholate [20]. The 
micelles prepared from the CoQ10 formulation products were added to monolayers of Caco-2 cells to 
determine the amounts of CoQ10 uptake. Their data demonstrated significantly enhanced uptake of 
CoQ10 from CoQ10-ȖCD complex as compared with pure CoQ10 powder and the other formulations. 
Here we had similar results using in vitro human epidermis structure model as well as Caco-2 cell model. 
Outstandingly high CoQ10 uptake in the tissue culture of human epidermic cell (keratinocytes) was 
observed when a solution prepared from CoQ10-ȖCD complex with GZK2 is applied in comparison with 
the other usual cosmetic formulations using liposome and fatty oil based emulsifiers (Fig. 9). 
The processes of aging and photo-aging are associated with an increase in cellular oxidation. This is in 
part due to a decline in the levels of the endogenous cellular antioxidant CoQ10. U. Hoppe et al. 
demonstrated that topical application of CoQ10 is effective against UVA mediated oxidative stress in 
human keratinocytes [21]. Furthermore, the topical application of CoQ10 was able to significantly 
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suppress the expression of callagenase in human dermal fibroblasts to be effective to reduce wrinkle depth. 
But higher concentration of CoQ10 than 0.3 wt % in cosmetic formulation was required in order to have 
the efficacy to prevent many of detrimental effects of photo-aging in spite that upper limit of CoQ10 
concentration is restricted to be 0.03 wt % in cosmetics in Japan. Accordingly our finding may contribute 
the developments of effectual photo-aging care products containing CoQ10. 
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Fig. 9. Uptake changes of CoQ10 into human epidermis structure modelby using various CoQ10 formulations, CoQ10 with oil 
based emulsifier (commercial product), CoQ10 liposome formulation (commercial product), CoQ10-ȖCD complex with GZK2, 
CoQ10 with GZK2, CoQ10-ȖCD complex, pure CoQ10. 
4. Conclusions 
Natural lipophilic bioactives possessing human health benefits like CoQ10 have some unfavorable 
characteristics for use as nutra-ceuticals and cosme-ceuticals in general. They are usually unstable against 
oxygen, ultraviolet light and heat. Their water solubility is low due to the hydrophobic nature which 
causes its low bioavailability to our human body. Therefore we focused on the systematically studies 
regarding the improvements of low stability, low water solubility and low bioavailability of lipophilic 
bioactives by the complexation with ȖCD and finally discovered new nanotechnology by the formation of 
“molecular captured micelle” as a breakthrough of our studies. The water solubility and bioavailability 
enhancing mechanism is as follows; When Na TCA or GZK2 is added to a water dispersion of CoQ10-
ȖCD complex, the guest molecule, CoQ10 is substituted by Na TCA or GZK2 whose association constant 
is higher than CoQ10 followed by the formation of water soluble Na TCA- or GZK2-ȖCD complex. The 
dissociated CoQ10 molecules are surrounded by surface-active Na TCA or GZK2 to form a few 
nanometer size molecular captured micelles. The water solubility of CoQ10 could be greatly enhanced by 
this molecular captured micelle formation with GZK2. It is therefore supposed to contribute the excellent 
permeability of CoQ10 into epidermis. The bioavailability enhancement can be explained in the same way. 
Nano-size micelles of commercially available “Water soluble CoQ10” using fatty oil based emulsifiers 
are the micelles to which CoQ10 flocculates with more than 100 nm diameter. Since bile acid has the 
same property as GZK2 for molecular substitution of ȖCD complex, it is easily imaginable that CoQ10 
molecules form bile acid micelles and as the result the absorption of CoQ10 in the intestine is enhanced 
(Fig. 10).  
This innovative molecular captured micelle formation nanotechnology introduced here, useful for the 
enhancement of bioavailability and epidermis permeability, is applicable for not only CoQ10 but also the 
other lipophilic bioactives such as Curcumin, R-Į-Lipoic acid and Tocotrienol. 
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Fig. 10. Proposed mechanism for the formation of “molecular captured micelle”. When Na TCA or GZK2 is added to a water 
dispersion of lipophilic bioactive-CD complex, the guest molecule is substituted by Na TCA or GZK2 whose association constant is 
higher than the guest molecule followed by the formation of water soluble Na TCA- or GZK2-ȖCD complex. The dissociated guest 
molecules are surrounded by surface-active Na TCA or GZK2 to form “molecular captured micelles” 
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